EPZM · Categories · Form 4

EPZM - SEC Form 4 insider transactions

Epizyme Inc. (EPZM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EPZM

• 1388d
  SEC Form 4: Giordano Michael F returned 17,054 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Goldfischer Carl returned 3,403,005 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Conroy Kevin T returned 62,318 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Richon Victoria returned 22,608 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Mott David M returned 8,994 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Beveridge, Roy A returned 46,037 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Agarwal Shefali returned 286,539 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4 filed by Legorreta Pablo G.

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4 filed by Korn Jerald

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Beaulieu Joseph returned 52,076 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Bate Kenneth returned 17,054 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Kutok Jeffery returned 120,067 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Stuckley Carol returned 25,696 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1388d
  SEC Form 4: Bogle Grant C. returned 259,170 shares to the company, closing all direct ownership in the company

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1393d
  SEC Form 4: Bogle Grant C. exercised 1,217,500 shares at a strike of $1.40 and covered exercise/tax liability with 1,141,390 shares, increasing direct ownership by 42% to 259,170 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1393d
  SEC Form 4: Agarwal Shefali exercised 500,000 shares at a strike of $1.39 and covered exercise/tax liability with 373,154 shares, increasing direct ownership by 80% to 285,562 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1393d
  SEC Form 4: Beaulieu Joseph covered exercise/tax liability with 279,864 shares and exercised 300,000 shares at a strike of $1.39, increasing direct ownership by 65% to 51,099 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1393d
  SEC Form 4: Kutok Jeffery exercised 380,000 shares at a strike of $1.39 and covered exercise/tax liability with 354,496 shares, increasing direct ownership by 27% to 120,067 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1430d
  SEC Form 4: Mott David M was granted 16,156 shares, increasing direct ownership by 8% to 224,488 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1430d
  SEC Form 4: Beveridge, Roy A was granted 8,928 shares, increasing direct ownership by 24% to 46,037 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1430d
  SEC Form 4: Conroy Kevin T was granted 10,204 shares, increasing direct ownership by 20% to 62,318 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4 filed by Legorreta Pablo G.

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Bate Kenneth was granted 8,994 shares, increasing direct ownership by 112% to 17,054 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Richon Victoria was granted 8,994 shares, increasing direct ownership by 66% to 22,608 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Stuckley Carol was granted 8,994 shares, increasing direct ownership by 54% to 25,696 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Giordano Michael F was granted 8,994 shares, increasing direct ownership by 112% to 17,054 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Mott David M was granted 8,994 shares, increasing direct ownership by 5% to 208,332 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Conroy Kevin T was granted 8,994 shares, increasing direct ownership by 21% to 52,114 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Goldfischer Carl was granted 8,994 shares, increasing direct ownership by 69% to 22,054 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1477d
  SEC Form 4: Beveridge, Roy A was granted 8,994 shares, increasing direct ownership by 32% to 37,109 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1513d
  SEC Form 4: Kutok Jeffery sold $2,467 worth of shares (2,741 units at $0.90) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 94,563 units (withholding obligation)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1522d
  SEC Form 4 filed by Korn Jerald

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1525d
  SEC Form 4: Beveridge, Roy A was granted 11,413 shares, increasing direct ownership by 68% to 28,115 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1525d
  SEC Form 4: Mott David M was granted 20,653 shares, increasing direct ownership by 12% to 199,338 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1525d
  SEC Form 4: Conroy Kevin T was granted 13,043 shares, increasing direct ownership by 43% to 43,120 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1536d
  SEC Form 4 filed by Bogle Grant C.

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1536d
  SEC Form 4: Beaulieu Joseph was granted 2,331 shares, increasing direct ownership by 8% to 30,963 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1536d
  SEC Form 4 filed by Kutok Jeffery

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1536d
  SEC Form 4: Agarwal Shefali was granted 2,331 shares, increasing direct ownership by 1% to 158,716 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1576d
  SEC Form 4: Beaulieu Joseph sold $333 worth of shares (222 units at $1.50) as part of a pre-agreed trading plan, decreasing direct ownership by 0.77% to 28,632 units to satisfy tax liability

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1576d
  SEC Form 4: Agarwal Shefali sold $1,587 worth of shares (1,058 units at $1.50) as part of a pre-agreed trading plan, decreasing direct ownership by 0.67% to 156,385 units (tax withholding)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1581d
  SEC Form 4: Beaulieu Joseph sold $941 worth of shares (687 units at $1.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 28,854 units to cover taxes

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1581d
  SEC Form 4: Agarwal Shefali sold $3,615 worth of shares (2,639 units at $1.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 157,443 units (for tax liability)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1581d
  SEC Form 4: Kutok Jeffery sold $3,502 worth of shares (2,556 units at $1.37) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 97,304 units to satisfy tax liability

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1581d
  SEC Form 4: Bogle Grant C. was granted 87,500 shares, increasing direct ownership by 92% to 183,060 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1584d
  SEC Form 4: Legorreta Pablo G. bought $34,000,000 worth of shares (22,666,667 units at $1.50)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1588d
  SEC Form 4: Agarwal Shefali sold $5,902 worth of shares (2,922 units at $2.02) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 160,082 units (withholding tax)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1612d
  SEC Form 4: Mott David M was granted 9,500 shares, increasing direct ownership by 6% to 178,685 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1612d
  SEC Form 4: Conroy Kevin T was granted 6,000 shares, increasing direct ownership by 25% to 30,077 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1640d
  SEC Form 4: Agarwal Shefali sold $5,215 worth of shares (1,780 units at $2.93) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 163,004 units (for tax liability)

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1659d
  SEC Form 4: Beveridge, Roy A was granted 16,702 shares

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1659d
  SEC Form 4: Stuckley Carol was granted 16,702 shares

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1707d
  SEC Form 4: Mott David M was granted 4,640 shares, increasing direct ownership by 3% to 169,185 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1707d
  SEC Form 4: Conroy Kevin T was granted 2,930 shares, increasing direct ownership by 14% to 24,077 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1751d
  SEC Form 4: Kutok Jeffery was granted 45,832 units of Common Stock, increasing direct ownership by 85% to 99,860 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1751d
  SEC Form 4: Beaulieu Joseph was granted 14,833 units of Common Stock, increasing direct ownership by 110% to 28,264 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1751d
  SEC Form 4: Ros Matthew was granted 28,125 units of Common Stock, increasing direct ownership by 34% to 111,313 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1751d
  SEC Form 4: Bogle Grant C. was granted 87,500 units of Common Stock, increasing direct ownership by 1,086% to 95,560 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1751d
  SEC Form 4: Agarwal Shefali was granted 59,166 units of Common Stock, increasing direct ownership by 57% to 163,507 units

  4 - Epizyme, Inc. (0001571498) (Issuer)
• 1799d
  SEC Form 4 filed by Epizyme, Inc.

  4 - Epizyme, Inc. (0001571498) (Issuer)

Other EPZM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends